Allied Biotech Corp

Allied Biotech Corp

TTPEX:1780
23.10
TWD
-0.50
(-2.12%)
0.69EPS
36.83P/E
2.77BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
5.07
5.02
5.54
6.06
7.21
8.09
6.74
6.5
7.1
7.51
7.53
8.41
8.83
5.09
Basic EPS, GAAP
0.07
0.07
0.49
0.43
0.75
1.41
1.13
0.84
0.14
1.54
1.02
1.05
1.35
0.69
Free Cash Flow per Basic Share
-0.78
-0.4
0.9
1.12
0.49
1.23
0.78
0.03
0.24
1.15
0.94
2.05
1.91
0.99
Dividend per Share
- -
- -
- -
0.4
0.45
0.66
1
1
0.8
0.5
1.2
0.85
1
- -
Book Value per Share
10.39
10.48
10.95
11.01
11.29
11.98
12.18
12.04
11.34
12.41
12.2
12.45
12.83
13.9
Tangible Book Value per Share
10.39
10.48
10.95
11.01
11.29
11.98
12.18
12.04
11.34
12.41
12.2
12.45
12.83
13.9
Basic Weighted Avg Shares
95
95
95
95
95
95
95
95
95
95
96
96
96
98
Sales/Revenue/Turnover
480
474
524
574
682
765
639
618
677
717
720
807
850
498
Operating Margin (%)
0.36
2.79
9.79
11.1
13.18
19
20.95
16.78
16.5
14.2
12.31
10.92
14.17
17.13
Depreciation Expense
38
44
47
46
50
53
57
62
65
72
69
62
61
30
Net Income, GAAP
6
7
46
40
71
133
107
79
13
147
97
101
129
67
Effective Tax Rate (%)
25.27
26.22
13.86
23.93
18.78
18.78
21.39
21.72
25.81
20.7
20.4
22.38
21.12
21.21
Profit Margin (%)
1.33
1.48
8.84
7.01
10.42
17.44
16.72
12.86
1.93
20.47
13.52
12.51
15.24
13.52
Working Capital
556
561
609
628
633
690
658
614
439
640
628
667
721
897
LT Debt
254
266
246
225
205
185
144
130
1
93
72
61
39
27
Total Equity
983
991
1,036
1,042
1,068
1,133
1,156
1,145
1,082
1,184
1,169
1,196
1,235
1,516
Return on Invested Capital (%)
0.1
0.69
3.03
3.37
4.99
7.54
6.2
4.02
3.7
3.61
3.5
3.3
4.58
3.16
Return on Capital (%)
0.72
0.8
3.55
3.09
5.17
8.91
6.54
4.35
0.96
7.17
5.4
5.43
6.95
3.41
Return on Common Equity (%)
0.65
0.71
4.57
3.87
6.73
12.13
9.34
6.91
1.17
12.96
8.28
8.54
10.65
4.9

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
695
694
724
LT Borrowings
34
30
25
LT Finance Leases
4
3
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
96
96
109
Market Capitalization
2,223
2,498
2,765

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,521
1,544
1,898
Cash, Cash Equivalents & STI
854
852
1,216
Accounts Receivable, Net
137
158
164
Inventories
511
508
483
Total Current Liabilities
800
863
1,001
Payables & Accruals
- -
- -
- -
ST Debt
695
694
724
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.85%
1.64%
3.27%
Free Cash Flow
121.24%
245.59%
-6.82%
Net Income, GAAP
104.55%
187.96%
28.25%
Sales/Revenue/Turnover
5.4%
6.64%
5.28%
Total Cash Common Dividend
- -
14.4%
17.94%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
234
194
193
186
807
2025
210
216
210
214
850
2026
240
258
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.27
0.44
0.2
0.14
1.05
2025
0.63
-0.46
0.67
0.51
1.35
2026
0.4
0.29
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.85
2025
- -
- -
- -
- -
1
2026
- -
- -
- -
- -
- -

Company Description

CEO
Ching Hui Lin
Full Time Employees
186
Sector
Consumer non-durables
Industry
Food: specialty/candy
Address
No. 71, Tun Hua South Road Taipei TPQ Taiwan 106045
IPO Date
Apr 29, 2010
Business
Allied Biotech Corporation engages in the global development, production, and distribution of carotenoid compounds and associated nutritional ingredients. The company offers a comprehensive range of products, including Beta-Carotene, which imparts yellow to reddish-orange shades across numerous applications, and Beta-Apo-8'-Carotenal, serving as a versatile food colorant with orange to red hues. Their portfolio also features Lycopene, valued for its red tones and nutritional benefits in food, dietary supplements, and pharmaceutical formulations, as well as Canthaxanthin, providing reddish-orange coloration for food and beverages and serving as a feed additive for poultry and aquaculture. Additionally, Allied Biotech supplies Lutein, a significant carotenoid found naturally in various green leafy vegetables and egg yolks, and Nano Coenzyme Q10, a vital antioxidant integral to the body's energy metabolic processes. Allied Biotech Corporation serves a broad spectrum of industries globally, encompassing food, beverage, dietary supplement, animal feed, pharmaceutical, and cosmetics sectors. The company, established in Taipei, Taiwan in 2001, has evolved into a prominent manufacturer in the carotenoid market, recognized for its full product line and patented production technologies.